Risky Business: Stratifying VTE and Managing Anticoagulation
Release Date: 04/25/2025
Risky Business: Stratifying VTE and Managing Anticoagulation
Clot, Clot, Who's There?
Join host Dr. Kerstin de Wit as she welcomes Drs. Cecilia Becattini and Behnood Bikdeli to unpack one of the most nuanced challenges in thrombosis care: venous thromboembolism (VTE) risk stratification and anticoagulation management. This case-based conversation explores: How clinicians navigate decisions around continuing, reducing, or stopping anticoagulation Whether formal risk scores or D-dimer testing guide us—or just add noise The complexities of provoked vs. unprovoked VTE Approaches to shared decision-making Novel therapies on the horizon Tune in now and subscribe...
info_outline
Sex as a Risk Factor for AF-related Stroke
Clot, Clot, Who's There?
Does sex influence the risk of atrial fibrillation (AF)-related strokes? Is female sex truly an independent risk factor? And what common myths still cloud clinical understanding? In this episode, host Dr. Giulio Francesco Romiti (internal medicine specialist from Sapienza University of Rome, Italy) is joined by guests Dr. Geoff Barnes (cardiologist and vascular medicine specialist, University of Michigan, USA) and Dr. Bernadette Corica (internal medicine specialist and cardiologist in training in Modena, Italy, and honorary research fellow at the Liverpool Centre for Cardiovascular...
info_outline
The Burden of Atrial Fibrillation
Clot, Clot, Who's There?
In this inaugural episode of Clot Clot Who’s There, global experts Professor Tatjana Potpara (Serbia), and Dr. Annabelle Volgman (USA) join moderator Dr. Panteleimon Papakonstantinou (Ireland) to discuss the rising global prevalence of atrial fibrillation (AF), a leading contributor to strokes and heart failure. They explore regional differences in AF management, evolving guidelines, and the potential of new treatments and technologies. With a focus on prevention, disparities in care, and the importance of early and individualized interventions, this discussion highlights critical pathways...
info_outlineJoin host Dr. Kerstin de Wit as she welcomes Drs. Cecilia Becattini and Behnood Bikdeli to unpack one of the most nuanced challenges in thrombosis care: venous thromboembolism (VTE) risk stratification and anticoagulation management.
This case-based conversation explores:
-
How clinicians navigate decisions around continuing, reducing, or stopping anticoagulation
-
Whether formal risk scores or D-dimer testing guide us—or just add noise
-
The complexities of provoked vs. unprovoked VTE
-
Approaches to shared decision-making
-
Novel therapies on the horizon
Tune in now and subscribe to stay updated in expert insights in thrombosis and cardiovascular medicine!